Gifford’s Ice Cream Resumes Production at Maine Facility Following Fire Incident

Gifford’s Ice Cream Resumes Production After Fire at Maine Plant

Gifford’s Ice Cream is back in action at its Skowhegan, Maine, plant after a year-long hiatus. The return to production comes following a devastating fire that struck the facility last year, leading to extensive damage and a halt in production. In response, the ice cream company turned to out-of-state co-packers to help meet customer demand.

Lindsay Skilling, CEO of Gifford’s Ice Cream, reflected on the challenges faced since the fire, stating, “The damage was so extensive we had to take most of our factory and offices down to the studs. It has been a year of pivoting and problem-solving. We can say now that the path forward hasn’t always been clear. But we never questioned our commitment to coming back stronger and better than ever. It feels great to be making our own ice cream again in Skowhegan.”

To resume production, the family-owned company has set up a smaller production area, currently operating at about 30% capacity compared to the full restoration goal. Two production lines are running to create quarts and bulk flavors for wholesale customers, while efforts are ongoing to rebuild offices and expand the production area. Popular flavors like Toasted Coconut and Black Raspberry Chocolate Chip Frozen Yogurt, previously unavailable through co-packers, are now in production.

JC Gifford, COO of Gifford’s Ice Cream, mentioned, “Our first run of Toasted Coconut and Black Raspberry Chocolate Chip Frozen Yogurt should start to hit grocery stores by mid-March. This is a significant milestone in restoring our full product lineup post-fire.” The company plans to gradually phase out co-packer partnerships and increase in-house production capacity over the months ahead.

Gifford’s HomeMaine Ice Cream, a fifth-generation family-owned business, prides itself on traditional ice cream-making practices using fresh, local ingredients. With a focus on quality and flavor, Gifford’s has garnered multiple awards for its premium ice cream products and holds partnerships with various New England sports teams. As the company works to regain full production capabilities by the end of 2024, customers can look forward to enjoying their favorite Gifford’s ice cream flavors once again.

spot_img

More from this stream

Recomended

Critical 90 Days Ahead: How Beijing Plans to Navigate the Trade War with the US for Lasting Solutions

Stay informed on China's strategic focus as the 90-day tariff pause approaches, exploring what the country hopes to gain from U.S. negotiators. Discover insights from The Converser on this critical economic situation.

Trump’s Middle East Contracts: A Step Closer or Still Far from His Ultimate Deals?

Discover how Trump navigated the complex situation in Gaza, avoided discussions on Israel, and presented no fresh proposals regarding Iran’s nuclear program, as analyzed by The Converser.

“Exciting Signs of Life Beyond Earth: Why a Healthy Dose of Skepticism Is Still Essential”

Discover how the recent detection of a gas in a distant planet, potentially linked to life forms, is stirring debate among scientists. Stay informed with insights from The Converser.

“Unlocking Economic Power: How Gulf States Fuel US Dominance Beyond Presidential Perks”

Discover how oil revenue from the Middle East frequently flows into the U.S. economy, shaping global financial dynamics. Learn more from The Converser.

“Exploring Tove Jansson’s Moomins: A Playful Critique of Artistic Struggles and Financial Pressures”

Discover how The Converser reveals that the comic industry provided Tove Jansson with financial stability while also challenging her creative process. Explore the balance between financial success and artistic freedom.

Unlocking Nature’s Secret: Boost GLP-1 Naturally Through Your Diet for Healthier Living!

Discover drug-free methods for boosting GLP-1 levels to support weight loss and healthy eating. The Converser explores natural approaches that offer effective alternatives to medication.